Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2010 Mar;9(3):254-63.
doi: 10.1016/S1474-4422(10)70023-5. Epub 2010 Feb 3.

Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data

Diederik van de Beek  1 , Jeremy J Farrar, Jan de Gans, Nguyen Thi Hoang Mai, Elizabeth M Molyneux, Heikki Peltola, Tim E Peto, Irmeli Roine, Mathew Scarborough, Constance Schultsz, Guy E Thwaites, Phung Quoc Tuan, A H Zwinderman
Affiliations
Meta-Analysis

Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data

Diederik van de Beek et al. Lancet Neurol. 2010 Mar.

Abstract

Background: Dexamethasone improves outcome for some patients with bacterial meningitis, but not others. We aimed to identify which patients are most likely to benefit from dexamethasone treatment.

Methods: We did a meta-analysis of individual patient data from the randomised, double-blind, placebo-controlled trials of dexamethasone for bacterial meningitis in patients of all ages for which raw data were available. The pre-determined outcome measures were death at the time of first follow-up, death or severe neurological sequelae at 1 month follow-up, death or any neurological sequelae at first follow-up, and death or severe bilateral hearing loss at first follow-up. Combined odds ratios (ORs) and tests for heterogeneity were calculated using conventional Mantel-Haenszel statistics. We also did exploratory analysis of hearing loss among survivors and other exploratory subgroup analyses by use of logistic regression.

Findings: Data from 2029 patients from five trials were included in the analysis (833 [41.0%] aged <15 years). HIV infection was confirmed or likely in 580 (28.6%) patients and bacterial meningitis was confirmed in 1639 (80.8%). Dexamethasone was not associated with a significant reduction in death (270 of 1019 [26.5%] on dexamethasone vs 275 of 1010 [27.2%] on placebo; OR 0.97, 95% CI 0.79-1.19), death or severe neurological sequelae or bilateral severe deafness (42.3%vs 44.3%; 0.92, 0.76-1.11), death or any neurological sequelae or any hearing loss (54.2%vs 57.4%; 0.89, 0.74-1.07), or death or severe bilateral hearing loss (36.4%vs 38.9%; 0.89, 0.73-1.69). However, dexamethasone seemed to reduce hearing loss among survivors (24.1%vs 29.5%; 0.77, 0.60-0.99, p=0.04). Dexamethasone had no effect in any of the prespecified subgroups, including specific causative organisms, pre-dexamethasone antibiotic treatment, HIV status, or age. Pooling of the mortality data with those of all other published trials did not significantly change the results.

Interpretation: Adjunctive dexamethasone in the treatment of acute bacterial meningitis does not seem to significantly reduce death or neurological disability. There were no significant treatment effects in any of the prespecified subgroups. The benefit of adjunctive dexamethasone for all or any subgroup of patients with bacterial meningitis thus remains unproven.

Funding: Wellcome Trust UK.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Literature search
Figure 2
Figure 2
Subgroup analyses for death BM=bacterial meningitis. OR=odds ratio.
Figure 3
Figure 3
Subgroup analyses for death BM=bacterial meningitis. OR=odds ratio.
Figure 4
Figure 4
Effect of adjunctive dexamethasone therapy on death Trials included in the rest of this study, , , , and other studies, , , , , , , , , , , , , , , , included in the Cochrane systematic review are shown. OR=odds ratio. *Study 1 in Lebel. †Study 2 in Lebel.
See this image and copyright information in PMC

Comment in

References

    1. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351:1849–1859. - PubMed
    1. van de Beek D, de Gans J, Tunkel AR, Wijdicks EF. Community-acquired bacterial meningitis in adults. N Engl J Med. 2006;354:44–53. - PubMed
    1. Saez-Llorens X, McCracken GH., Jr. Bacterial meningitis in children. Lancet. 2003;361:2139–2148. - PubMed
    1. Scarborough M, Thwaites GE. The diagnosis and management of acute bacterial meningitis in resource-poor settings. Lancet Neurol. 2008;7:637–648. - PubMed
    1. Scheld WM, Dacey RG, Winn HR, Welsh JE, Jane JA, Sande MA. Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis: alterations with penicillin and methylprednisolone. J Clin Invest. 1980;66:243–253. - PMC - PubMed

Publication types